The Alberleen Group
  • Home
  • What We Are
  • Who We Serve
    • Family Offices
    • Companies
    • Private Equity & Financial Sponsors
  • What We Do
  • Our Senior Team
  • Things of Interest
  • Contact Us

Things of interest

Alberleen Family Office Solutions proudly hosted a Lunch n’ Learn session with TC Biopharm

6/14/2019

 
June 5th – Alberleen Family Office Solutions (AFOS) proudly hosted a Lunch n’ Learn session for clinical stage cell therapy company TC Biopharm. TCB is based in Scotland and was founded by cell therapy veteran CEO Michael Leek. It is developing allogeneic Gamma Delta T-Cell therapies for patients in a number of oncology indications and has expanded that unique, proprietary platform to begin developing dual activated CAR-T therapies. CEO Leek and his team are dedicated to developing low cost, broadly accessible cell therapy treatments for cancer and have made great strides to become the leader in the allogeneic cell therapy sector. 
TC Biopharm has announced partnerships with drug development behemoths such as bluebird bio (Nasdaq: BLUE) and NIPRO Japan, where they are exploring applications for Gamma Delta T-Cell therapy in indications such as Acute Myeloid Leukemia (AML), Melanoma, Non-Small Cell Lung Cancer (NSCLC) and a number of pediatric indications. CEO Leek discussed the Company’s completed clinical Phase 1/2 data in Melanoma, their Phase 1/2  trial structure and focus in AML and the developing CAR-T dynamic that could revolutionize the treatment paradigm of cancer, bringing off the shelf CAR-T treatments at significantly lower costs to patients.
 
To date, roughly $36 Million in capital has flowed into TC Biopharm, $24 Million in non-dilutive milestone payments from their partners and grants, and an additional $12 Million has been raised from investors such as Scottish Investment Bank.
 
We were excited to hear how Mike and his team have built such a potentially impactful therapeutic technology suite in such a short time since their founding roughly 6 years ago, and we thank all our attendees for joining us. 

For more information please contact, Bryan Kobel at Bryan@alberleen.com (212) 993-7422

Comments are closed.

    Upcoming events

    Mar. 10
    AFOS CEO/CIO Adam Goodfriend on ACG Family Office panel 
    New York, NY

    PAst Events

    Feb. 4-6
    Alberleen Family Office Innovation Summit in Salt Lake City, UT
Home
What We Are
What We Do
Our Senior Team
Family Offices
Companies
Private Equity & Financial Sponsors
Things of Interest
Contact Us
Terms of Use
Picture
Copyright © 2020.  All rights reserved.
None of the information contained in this web site constitutes a recommendation, solicitation or offer by Alberleen or its affiliates to buy or sell any securities or other financial instruments of any person or provide any investment advice or service.  All securities are offered exclusively through Worden Capital Management, a broker-dealer member of FINRA and SIPC.
  • Home
  • What We Are
  • Who We Serve
    • Family Offices
    • Companies
    • Private Equity & Financial Sponsors
  • What We Do
  • Our Senior Team
  • Things of Interest
  • Contact Us